Biodexa’s Licensor Emtora to Announce Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis to be Presented at Prestigious 2024 Digestive Disease Week Annual Meeting

9d ago

BDRX

PremiumCompany Announcements

Biodexa Pharmaceuticals Seals Deal with Emtora Biosciences

13d ago

BDRX

PremiumPress Releases

Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP)

13d ago

BDRX

PremiumCompany Announcements

Navigating Uncertainty: Biodexa Pharmaceuticals and the Impact of Geopolitical Turmoil on Pharma’s Bottom Line

20d ago

BDRX

PremiumCompany Announcements

Biodexa Pharmaceuticals Reports 2023 Milestones

20d ago

BDRX

PremiumPress Releases

Biodexa Announces Positive Top Line Phase I Clinical Trial Results for Diffuse Midline Glioma and Provides R&D Update

3M ago

BDRX

More BDRX News >

BDRX News on the Web

2024-04-30

Biodexa’s eRapa Shows Promise for FAP Treatment

TipRanks News

Neutral

2024-04-30

Biodexa’s Licensor Emtora to Announce Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis to be Presented at Prestigious 2024 Digestive Disease Week Annual Meeting

Yahoo Finance

Neutral

2024-04-29

Why Is Inno (INHD) Stock Up 46% Today?

InvestorPlace

Neutral

2024-04-26

Why Is Biodexa (BDRX) Up 70% Today?

InvestorPlace

Neutral

2024-04-26

Biodexa Pharmaceuticals Seals Deal with Emtora Biosciences

TipRanks News

Neutral

2024-04-26

Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis

Yahoo Finance

Neutral

2024-04-20

Navigating Uncertainty: Biodexa Pharmaceuticals and the Impact of Geopolitical Turmoil on Pharma’s Bottom Line

TipRanks News

Bearish

2024-03-28

Healthcare Stocks Moving Up and Down Thursday: AVTX, XLO, NXL, BDRX, KOD, AKBA, VINC, TOI

Investors Observer

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BDRX’s Media Buzz Sentiment?

Currently, no data Available

What is BDRX’s weekly average amount of articles?

Currently, no data Available

What is BDRX’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

AMRXAmneal Pharmaceuticals

SEMSelect Medical

GOSSGossamer Bio

STTKShattuck Labs

RCKTRocket Pharmaceuticals

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing